CD44 and ovarian carcinoma: Previous studies in fresh ovarian carcinoma samples have highlighted that OCSCs express specific markers, such as CD44, CD133, and aldehyde dehydrogenase (ALDH) activity, which are associated with stemness and may play a role in therapeutic resistance [40].